Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Cureus|July 28, 2025
Vitamin B6 Deficiency May Not Always Present As Microcytic Hypochromic AnemiaSanshiro Nakao, Chiaki Nakaseko, Takahiro Ishii, et al.Cancer Immunology, Immunotherapy : CII|August 17, 2011
Tissue expression of Toll-like receptors 2 and 4 in sporadic human colorectal cancerYasuhiro Nihon-Yanagi, Kensuke Terai, Takeyoshi Murano, et al.Journal of Healthcare Engineering|July 24, 2018
Gastric Pathology Image Classification Using Stepwise Fine-Tuning for Deep Neural NetworksJia Qu, Nobuyuki Hiruta, Kensuke Terai, et al.Biomedical Reports|March 21, 2014
β-2 microglobulin is unsuitable as an internal reference gene for the analysis of gene expression in human colorectal cancerYasuhiro Nihon-Yanagi, Kensuke Terai, Takeyoshi Murano, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 25, 2008
[Expression of toll-like receptor 4 in colorectal cancer]Yasuhiro Nihon-yanagi, Youngjin Park, Mitsuru Ooshiro, et al.Metabolism: Clinical and Experimental|April 24, 2012
Atorvastatin and pitavastatin enhance lipoprotein lipase production in L6 skeletal muscle cells through activation of adenosine monophosphate-activated protein kinaseMasahiro Ohira, Kei Endo, Atsuhito Saiki, et al.Experimental Cell Research|March 5, 2018
Heregulin-induced cell migration is promoted by aryl hydrocarbon receptor in HER2-overexpressing breast cancer cellsNaoya Yamashita, Nao Saito, Shuai Zhao, et al.Modern Rheumatology Case Reports|April 13, 2021
Rapidly destructive coxopathy due to dialysis amyloidosis: a case reportShiho Nakano, Arata Nakajima, Masato Sonobe, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|December 15, 2018
Levels of circulating soluble LR11, a regulator of smooth muscle cell migration, are highly associated with atherosclerotic plaques in patients with carotid artery stenosisMasashi Harada, Meizi Jiang, Kensuke Terai, et al.Biochemical and Biophysical Research Communications|June 30, 2019
Aryl hydrocarbon receptor counteracts pharmacological efficacy of doxorubicin via enhanced AKR1C3 expression in triple negative breast cancer cellsNaoya Yamashita, Yuichiro Kanno, Nao Saito, et al.Pageof 2